Product Information
RESTASIS 0.05% EYE EMULSION is a brand product labeled by Allergan, Inc., priced at $10.3179 per EA under NDC 00023916360. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the cyclosporine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023916360
Classification
Brand
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA050790On Market Since
4/1/2003
Pharmacological Classes
Price Statistics
The NADAC for RESTASIS 0.05% EYE EMULSION has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 115.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3179 per EA |
|---|---|
| All-time high | $10.3396 (Mar 15, 2023) |
| All-time low | $4.7953 (Nov 28, 2013) |
| 52-week high | $10.3269 |
| 52-week low | $10.3179 |
| Median price | $9.3658 |
| Average price | $8.6217 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RESTASIS 0.05% EYE EMULSION?
The current National Average Drug Acquisition Cost (NADAC) for RESTASIS 0.05% EYE EMULSION, manufactured by Allergan, Inc., is $10.3179 per EA (NDC 00023916360), effective Jun 24, 2026.
How has the price of RESTASIS 0.05% EYE EMULSION changed over time?
Over the history we have for it, the NADAC for RESTASIS 0.05% EYE EMULSION has risen 115.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RESTASIS 0.05% EYE EMULSION?
Since Nov 28, 2013, the NADAC for RESTASIS 0.05% EYE EMULSION has ranged from a low of $4.7953 (Nov 28, 2013) to a high of $10.3396 (Mar 15, 2023), with a median of $9.3658 per EA.
Are there cheaper alternatives to RESTASIS 0.05% EYE EMULSION?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CYCLOSPORINE 0.05% EYE EMULSION, is $1.0833 per EA — about 90% below RESTASIS 0.05% EYE EMULSION.
Who manufactures RESTASIS 0.05% EYE EMULSION?
RESTASIS 0.05% EYE EMULSION (NDC 00023916360) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification